SEC Form 4 · accession 0001209191-18-030106
Corbus Pharmaceuticals Holdings, Inc. · CRBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sean F. Moran
Officer — Chief Financial Officer
Period of report
May 15, 2018
Accepted (ET)
May 15, 2018 · 10:58 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001595097
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 15, 2018 | P | 4,000 | $5.77 | A | 348,010 | D |
Table II — derivative securities
No Table II lines on this filing.